Privia Health (PRVA) EBIT (2020 - 2026)

Privia Health has reported EBIT for 7 years, with the latest figure at $11.8 million in Q2 2026.

• On a quarterly basis, EBIT rose 252.91% year-over-year to $11.8 million in Q2 2026; TTM through Jun 2026 was $44.9 million, a 128.78% increase from a year earlier, with the FY2025 full-year figure at $34.2 million, up 101.6% from the prior year.
• EBIT was $11.8 million for Q2 2026 at Privia Health, up from $7.4 million in the prior quarter.
• The five-year high for EBIT was $14.4 million in Q3 2025, with the low at -$11.5 million in Q1 2022.
• Average EBIT over 5 years is $4.0 million, with a median of $5.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: EBIT plunged 246.04% in 2022, then surged 534.02% in 2025.
• Over 5 years, EBIT stood at $2.2 million in 2022, then tumbled by 36.86% to $1.4 million in 2023, then soared by 269.58% to $5.2 million in 2024, then surged by 114.9% to $11.3 million in 2025, then increased by 4.39% to $11.8 million in 2026.
• The last three EBIT figures came in at $11.8 million (Q2 2026), $7.4 million (Q1 2026), and $11.3 million (Q4 2025), per Business Quant data.